Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients.

Betul Oran, MD, MS, Michelle Dolan, MD, Linan Ma, M.S.P.H., Claudio Brunstein, MD, PhD, Erica Warlick, MD, Daniel J. Weisdorf, MD

Blood (2009) 114 (22): 525.

https://doi.org/10.1182/blood.V114.22.525.525

Published: 2009

Journal Articles

Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study.

Blood (2009) 114 (22): 663.

https://doi.org/10.1182/blood.V114.22.663.663

Published: 2009

Journal Articles

Delayed Platelet Recovery After Allogeneic Peripheral Blood, Marrow and Umbilical Cord Stem Cell Transplantation: Risk Factors and Clinical Outcomes.

Pablo A Ramirez, M.D., Claudio Brunstein, MD, PhD, Brian Miller, MD, Todd E. DeFor, MS, Daniel J. Weisdorf, MD

Blood (2009) 114 (22): 867.

https://doi.org/10.1182/blood.V114.22.867.867

Published: 2009

Journal Articles

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Brian McClune, DO, Linda J. Burns, MD, Todd E. DeFor, MS, Arne Slungaard, MD, Veronika Bachanova, Claudio Brunstein, MD, PhD, Daniel J. Weisdorf

Blood (2009) 114 (22): 3385.

https://doi.org/10.1182/blood.V114.22.3385.3385

Published: 2009

Journal Articles

Prolonged Survival in Adults with Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning and Allogeneic Transplantation

Veronika Bachanova, Daniel J. Weisdorf, Claudio Brunstein, MD, PhD, John Wagner, MD, Michael Verneris, MD

Blood (2008) 112 (11): 4415.

https://doi.org/10.1182/blood.V112.11.4415.4415

Published: 2008

Journal Articles

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Claudio Brunstein, MD, PhD, Daniel Weisdorf, Todd DeFor, Jeffrey S. Miller, MD, Philip B. McGlave, Bruce R. Blazar, MD, John E. Wagner, MD

Blood (2008) 112 (11): 1957.

https://doi.org/10.1182/blood.V112.11.1957.1957

Published: 2008

Journal Articles

Comparative Assessment of Weighting Comorbidities in the Hematopoietic Cell Transplantation (HCT) Specific Comorbidity Index (HCT-CI)

Todd E DeFor, MS, Navneet S. Majhail, MD, MS, Claudio Brunstein, MD, PhD, Daniel J. Weisdorf, MD, Chap T Le, PhD

Blood (2008) 112 (11): 798.

https://doi.org/10.1182/blood.V112.11.798.798

Published: 2008

Journal Articles

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Claudio Brunstein, MD, PhD, John E. Wagner, MD, Daniel Weisdorf, MD, Sarah Cooley, MD, Harriet Noreen, Juliet Barker, MBBS, Todd DeFor, Michael Verneris, MD, Philip B. McGlave, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 152.

https://doi.org/10.1182/blood.V112.11.152.152

Published: 2008

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

Journal Articles

Immunotherapy of EBV Post Solid Organ Transplantation Lymphoproliferative Disease with Genetically Engineered Haploidentical T Cells.

Paul J. Orchard, MD, Jakub Tolar, MD, PhD, Lisa Basso, Claudio Brunstein, MD, PhD, Marcie Tomblyn, MD, Scott Baker, MD, Bruce Blazar, MD, John Wagner, MD, Jeffrey S. Miller, MD

Blood (2005) 106 (11): 5541.

https://doi.org/10.1182/blood.V106.11.5541.5541

Published: 2005

Journal Articles

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

Michael R. Verneris, MD, Claudio Brunstein, MD, PhD, Todd E. DeFor, Juliet Barker, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E. Wagner, MD

Blood (2005) 106 (11): 305.

https://doi.org/10.1182/blood.V106.11.305.305

Published: 2005

NARROW

Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients.

Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study.

Delayed Platelet Recovery After Allogeneic Peripheral Blood, Marrow and Umbilical Cord Stem Cell Transplantation: Risk Factors and Clinical Outcomes.

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Prolonged Survival in Adults with Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning and Allogeneic Transplantation

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Comparative Assessment of Weighting Comorbidities in the Hematopoietic Cell Transplantation (HCT) Specific Comorbidity Index (HCT-CI)

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Immunotherapy of EBV Post Solid Organ Transplantation Lymphoproliferative Disease with Genetically Engineered Haploidentical T Cells.

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only